title: Managing HIV. Part 5: Treating secondary outcomes. 5.4 HIV-induced neurological disease.
authors.affiliation: HIV/AIDS Unit, Fairfield Hospital, Melbourne VIC, Australia.
authors.forename: E J
authors.initials: EJ
authors.lastname: Wright
authors.forename: B J
authors.initials: BJ
authors.lastname: Brew
authors.forename: J N
authors.initials: JN
authors.lastname: Currie
authors.forename: J C
authors.initials: JC
authors.lastname: McArthur
mesh_terms: D015526:AIDS Dementia Complex / Q000175:diagnosis / Q000517:prevention & control; D000998:Antiviral Agents / Q000627:therapeutic use; D001927:Brain Diseases / Q000821:virology; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D009422:Nervous System Diseases / Q000150:complications* / Q000821:virology; D010523:Peripheral Nervous System Diseases / Q000821:virology; D015215:Zidovudine / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D015215:Zidovudine